Skip to main content
. Author manuscript; available in PMC: 2012 Apr 6.
Published in final edited form as: AIDS. 2011 Nov 13;25(17):2133–2142. doi: 10.1097/QAD.0b013e32834be088

Figure 2. Effect of ART Treatment on Total HDL Particles and ApoA1 Levels when Stratified by Baseline Level of Inflammatory Biomarkers or HIV RNA.

Figure 2

The percent difference (VS-DC groups) at 6 months in total HDL-P and ApoA1 is presented separately for subgroups defined by baseline levels (in tertiles) of hsCRP, IL-6, and HIV RNA. The percent difference is adjusted for baseline level of HDL-P and ApoA1, respectively, and thus represents the change in these lipoprotein measures 6 months after starting ART. P-values represent the interaction term of baseline biomarker level and treatment effect at 6 months. The degree of improvement in total HDL-P and ApoA1 was dependent on the degree of inflammation (reflected in hsCRP and IL-6 levels), but not the HIV RNA level, at baseline.